Drug Exposure, Disease Characteristics Not Linked to Increased Mortality Risk in Patients with Multiple Myeloma Who Contracted COVID-19

September 17th 2020, 6:00pm

By Ryan McDonald

Specific disease characteristics of, and treatments for, multiple myeloma were not associated with increased mortality risk in patients with multiple myeloma who developed COVID-19, according to data published in Journal of Hematology & Oncology.

It’s Important to Keep Your Hope as We Head Into A Fall Filled with Uncertainty

September 17th 2020, 4:00pm

By Barbara Tako

We have all had times in our lives where everything goes wrong at once. We got through them, and we continue to get through them.

Pulling Back the Layers of Penile Cancer

September 17th 2020, 3:00pm

By Ryan McDonald

In this episode of the “CURE Talks Cancer” podcast, we spoke with an expert about some of the possible causes of penile cancer, as well as why research in the field is severely lacking and why it’s so important to inform the public about what to look for in terms of signs and symptoms of this disease.

Adding Immunotherapy to Radiotherapy Increases Survival in Patients with Brain Metastases

September 16th 2020, 9:00pm

By Conor Killmurray

The addition of immunotherapy to radiotherapy increased the overall survival of patients with cancer who developed brain metastases, according to new research.

Expert Connections: Hereditary Prostate Cancer

September 16th 2020, 7:40pm

By Nicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of Nevada

Higher Prescription Opioid Use Is Not Linked to Misuse Among Cancer Survivors, According to Recent Study

September 16th 2020, 6:30pm

By Jessica Skarzynski

Opioids are a common tool in treating cancer-related pain, but they are also at the center of a nationwide epidemic. One that researchers have found cancer patients are not as linked to as previously thought.

FDA Approves Expanded Use of CINtec PLUS Cytology Test in Preventing Cervical Cancer

September 16th 2020, 5:48pm

By Conor Killmurray

The Food and Drug Administration approved the expanded use of the biomarker test CINtec PLUS Cytology that looks at HPV related biomarkers that could lead to cervical cancer. This is the first triage test approved in this space.

There are No ‘Right’ Answers When it Comes to Cancer

September 16th 2020, 4:00pm

By Erica Finamore

As a caregiver, you rarely have 10 seconds to think or reflect on anything, but with my husband gone now, I find myself looking back more than ever. There are so many things we did right, and so many things I’ll probably always feel unsure of.

Sociodemographic Factors Suggest Barriers to Care for Patients with Metastatic Melanoma

September 16th 2020, 3:00pm

By Conor Killmurray

Recent immunotherapy approvals for patients with metastatic melanoma has widened the treatment landscape, but new research shows that patients associated with positive sociodemographic factors are more likely to receive immunotherapy.

Younger Adults, Women with Cancer Respond Less Well to Immunotherapy with Checkpoint Inhibitors

September 16th 2020, 1:00pm

By Ryan McDonald

Younger and female patients with a variety of cancer types tend to have strong immune systems that naturally fight an array of cancer cells. The tumor cells the immune system doesn’t destroy are the most evasive, both to the immune system and medications that boost its activity, and this makes checkpoint inhibitor immunotherapy less effective in this population.